Patents by Inventor Andrew J. Watson

Andrew J. Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9538002
    Abstract: Systems and methods of handling customer contacts at a customer care system that streamline the handling of such customer contacts based on information about previous contacts received from the same customers. The system includes a repeat contact engine, which is connectable to at least one data/communications network. The repeat contact engine includes a controller, at least one database communicably connected to the controller, and a data extractor communicably connected between the data/communications network and the database. The controller includes a server, a rule processor communicably connected to the server, and a policy engine associated with the rule processor. Based on information about at least one previous contact, the system can derive a rule that, in response to its application, would cause a predetermined response, representative of the predicted purpose of an incoming contact, to be provided over a corresponding channel through the data/communications network.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 3, 2017
    Assignee: Nuance Communications, Inc.
    Inventor: Andrew J. Watson
  • Publication number: 20140270107
    Abstract: Systems and methods of handling customer contacts at a customer care system that streamline the handling of such customer contacts based on information about previous contacts received from the same customers. The system includes a repeat contact engine, which is connectable to at least one data/communications network. The repeat contact engine includes a controller, at least one database communicably connected to the controller, and a data extractor communicably connected between the data/communications network and the database. The controller includes a server, a rule processor communicably connected to the server, and a policy engine associated with the rule processor. Based on information about at least one previous contact, the system can derive a rule that, in response to its application, would cause a predetermined response, representative of the predicted purpose of an incoming contact, to be provided over a corresponding channel through the data/communications network.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventor: Andrew J. Watson
  • Publication number: 20030114371
    Abstract: The present invention provides novel polynucleotides encoding K+betaM3 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel K+betaM3 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
    Type: Application
    Filed: February 7, 2002
    Publication date: June 19, 2003
    Inventors: John N. Feder, Liana Lee, Jian Chen, Donald Jackson, Chandra S. Ramanathan, Nathan O. Siemers, Han Chang, Rolf-Peter Ryseck, Andrew J. Watson, Pamela Carroll
  • Publication number: 20030104974
    Abstract: Dual inhibitors of PDE7 and PDE4, together with their use to treat leukocyte activation-associated disorders (including transplant rejection, rheumatoid arthritis, inflammatory bowel disease, psoriasis, asthma, chronic obstructive pulmonary disease, lupus and multiple sclerosis), are provided herein.
    Type: Application
    Filed: April 30, 2002
    Publication date: June 5, 2003
    Inventors: William J. Pitts, Andrew J. Watson, John H. Dodd
  • Patent number: 6322964
    Abstract: Peptide sequences are disclosed which immunologically mimic proteins encoded by the env and gag regions of LAV-2, a retrovirus associated with AIDS. The peptide can be used in various specific binding assays to detect the presence of antibodies to LAV-2 in individuals previously exposed to the virus. The peptides enable one to distinguish the presence of antibodies to LAV-2 from antibodies to HIV-1.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: November 27, 2001
    Assignees: Genetic Systems Corporation, Institut Pasteur
    Inventors: Wesley L. Cosand, Andrew J. Watson, Raymond L. Houghton, Luc Montagnier, Marc Alizon, Solange Chamaret